Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Peishan Cai"'
Publikováno v:
IUCrJ, Vol 11, Iss 1, Pp 23-33 (2024)
Fatty acid-derivative prodrugs have been utilized extensively to improve the physicochemical, biopharmaceutical and pharmacokinetic properties of active pharmaceutical ingredients. However, to our knowledge, the crystallization behavior of prodrugs m
Externí odkaz:
https://doaj.org/article/92fca16d592d4a1c8acfa3a96e741490
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used due to their profound efficacy in glycemic control and weight management. Within real-world contexts, the manifestation of certain psychiatric adverse events (AEs) has be
Externí odkaz:
https://doaj.org/article/d196a59092bd48b69bc81980cd4509b0
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-7 (2020)
Abstract Background A considerable proportion of patients hospitalized with coronavirus disease 2019 (COVID-19) acquired secondary bacterial infections (SBIs). The etiology and antimicrobial resistance of bacteria were reported and used to provide a
Externí odkaz:
https://doaj.org/article/273b348786344688bbab47ed61fc765f
Publikováno v:
Pharmaceutical Research. 40:567-577
The fixed-dose combination drug products have been increasingly used to treat some complex diseases. A cocrystal containing two therapeutic components, named as a drug-drug cocrystal, is an ideal solid form to formulate as a fixed-dose combination pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1e33d590e9cbcfbcbc33c4ec682fe7
https://doi.org/10.1007/s11095-022-03427-3
https://doi.org/10.1007/s11095-022-03427-3
Background Secondary bloodstream infection (SBI) is considered one of the most perilous complications of coronavirus disease 2019 (COVID-19). Although the etiology of SBI has been reported, the clinical course and outcomes of this illness have not be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16e11306635e08d5c137d6bfd5eb265f
https://doi.org/10.21203/rs.3.rs-530370/v1
https://doi.org/10.21203/rs.3.rs-530370/v1
Publikováno v:
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-7 (2020)
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-7 (2020)
Background A considerable proportion of patients hospitalized with coronavirus disease 2019 (COVID-19) acquired secondary bacterial infections (SBIs). The etiology and antimicrobial resistance of bacteria were reported and used to provide a theoretic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c383aa77f2c02630027a05714485ef9b
https://doi.org/10.1186/s13756-020-00819-1
https://doi.org/10.1186/s13756-020-00819-1
Background: Severe patients hospitalized with COVID-19 suffered secondary infections which greatly increased the length of hospital stay and the mortality. We aimed to explore risk factors of secondary infections that can help clinicians early implem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bde1b98845e2740aca0ca4d0a3854588
https://doi.org/10.21203/rs.3.rs-55958/v1
https://doi.org/10.21203/rs.3.rs-55958/v1